Catalyst Wire Dossier Catalyst Wire Dossier

Briviact

brivaracetam · UCB Pharma
Drug timelines are a Plus or Pro feature.

33 regulatory and trial events tracked for Briviact, covering 2016-02-18 to 2026-03-18. Get the full timeline:

Most recent: Clinical Trial Update: Brivaracetam to Reduce Neuropathic Pain in Chronic SCI: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial [Phase 3]

See pricing